NCT06057038 2026-03-03
A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors
Genmab
Phase 1 Active not recruiting
Genmab
Genmab
Jiangsu HengRui Medicine Co., Ltd.
Zai Lab (Hong Kong), Ltd.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Jiangsu HengRui Medicine Co., Ltd.
Bristol-Myers Squibb
Sanofi
Eli Lilly and Company
Nektar Therapeutics
amcure GmbH
Ono Pharmaceutical Co. Ltd
AstraZeneca
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Peregrine Pharmaceuticals
Eli Lilly and Company